cyclopentane has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, J; Al-Shamma, H; Carroll, C; Komori, HK; Lehmann-Bruinsma, K; Peyrin-Biroulet, L; Solomon, M | 1 |
| Choo, J; Im, E; Jung, JH; Kim, SJ; Lee, Y; Moon, HR; Noh, TH; Pothoulakis, C; Son, S; Yan, XJ | 1 |
2 other study(ies) available for cyclopentane and Colitis
| Article | Year |
|---|---|
The Selective Sphingosine 1-Phosphate Receptor Modulator Etrasimod Regulates Lymphocyte Trafficking and Alleviates Experimental Colitis.
Topics: Acetates; Animals; Biological Transport; Cell Count; Colitis; Cyclopentanes; Disease Models, Animal; Dogs; Heterocyclic Compounds, 3-Ring; Humans; Indoles; Lymphocytes; Male; Mice; Sphingosine-1-Phosphate Receptors | 2019 |
A Novel Peroxisome Proliferator-activated Receptor (PPAR)γ Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in Colitis.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Colitis; Cyclopentanes; Male; Mice; Mice, Inbred C57BL; Oxylipins; PPAR gamma; Transcription, Genetic | 2015 |